Furthermore, HSYA blocks angiogenesis of hepatocellular carcinoma through suppressing ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice [14], implicating the regulatory role of HSYA on the NF-κB signal pathway. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.